Compare MPLT & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPLT | WINA |
|---|---|---|
| Founded | 2018 | 1988 |
| Country | United States | United States |
| Employees | 133 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2006 |
| Metric | MPLT | WINA |
|---|---|---|
| Price | $28.57 | $363.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $32.67 | N/A |
| AVG Volume (30 Days) | ★ 253.4K | 32.6K |
| Earning Date | 05-28-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 3.76% |
| EPS Growth | N/A | ★ 3.76 |
| EPS | N/A | ★ 2.50 |
| Revenue | N/A | ★ $86,055,700.00 |
| Revenue This Year | N/A | $5.55 |
| Revenue Next Year | N/A | $6.03 |
| P/E Ratio | ★ N/A | $145.28 |
| Revenue Growth | N/A | ★ 5.86 |
| 52 Week Low | $12.24 | $338.18 |
| 52 Week High | $33.28 | $526.81 |
| Indicator | MPLT | WINA |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 43.25 |
| Support Level | $26.70 | $358.01 |
| Resistance Level | $32.23 | $483.43 |
| Average True Range (ATR) | 2.34 | 13.11 |
| MACD | -0.40 | 1.85 |
| Stochastic Oscillator | 58.24 | 61.47 |
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.